Pfizer warns that a Covid vaccine patent waiver could harm supply and safety

Original article by Paul Karp
The Guardian Australia – Page: Online : 13-May-21

Australia is continuing to resist a global push to waive intellectual property protections for COVID-19 vaccines. Pfizer has used its submission to a parliamentary inquiry into vaccine fraud to argue that rather than increasing global supply of vaccines, a waiver may in fact make it more difficult to manufacture vaccines due to increased competition for raw materials. Pfizer has also highlighted the increased risk of Australians being offered counterfeit vaccines by scammers. Meanwhile, Moderna has advised that the federal government has agreed to buy 25 million doses of its mRNA-based vaccine, including 10 million doses in 2021. It is also holding talks about manufacturing the two-dose vaccine in Australia.

CORPORATES
PFIZER AUSTRALIA PTY LTD, PFIZER INCORPORATED, MODERNA INCORPORATED